Cytokine IL-6 initiates the CRS in the MAPK/NF-κB-IL-6 or JAK-STAT pathway (63), and as an infection trigger, IL-6 has been associated with the symptom progression in this disease (64). This evidence concerns the gene IL6 and infection.